On the BSE, 29,000 shares were traded in the counter so far compared with average daily volumes of 1.10 lakh shares in the past two weeks. The stock had hit a high of Rs 433.05 and a low of Rs 421.65 so far during the day.
The stock hit a record high of Rs 558 on 12 June 2017. The stock hit a 52-week low of Rs 356.30 on 16 February 2017.
Cadila Healthcare announced that the US Food and Drug Administration (USFDA) inspected the company's Moraiya facility in Gujarat from 5 February to 9 February 2018. At the end of the inspection, no observation (483) was issued.
On a consolidated basis, net profit of Cadila Healthcare rose 71.64% to Rs 542.90 crore on 41.88% rise in net sales to Rs 3191.80 crore in Q3 December 2017 over Q3 December 2016.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)